South Korea Blood Typing and Grouping Reagents Market Insight
Published: 31 August 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The South Korea blood typing market is going to grow a lot. It is expected to grow at a rate of 10.2% from 2025 to 2030. This growth is happening because there are blood transfusions, better diagnostic facilities hospitals are getting modernized and there is a need to know the correct blood group of patients.
Market Insights and Forecasts to 2035
- South Korea blood typing Market Size 16.7 million USD in 2024
- The Market Size is Expected to Grow at a CAGR of around 10.2% from 2025 to 2035
- The South Korea blood typing Market Size is Expected to rise around 30.0 million USD by 2030
Notable Insights for the South Korea Market
- The By product type based segmentation suggests that the Consumables & Reagents controllers items segment leads in the South Korea Blood Typing and Grouping Reagents Market Insight due to the recurring demand for routine blood typing and compatibility testing.
- The By end users based segmentation suggests that the Hospitals and Blood Banks controllers items segment leads in the South Korea Blood Typing and Grouping Reagents Market Insight due to the increasing demand for blood transfusion testing and safe blood management.
- The South Korea Blood Typing and Grouping Reagents Market Insight is competitive with companies like Bio-Rad Laboratories, Grifols, Danaher Corporation, and Thermo Fisher Scientific being involved in the development and supply of innovative blood typing and grouping reagents and transfusion diagnostic solutions.
Download the eBook (ToC)
Research Methodologies Used to Analyze the South Korea blood typing market
The South Korea blood typing Market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with blood typing market manufacturers and distributors, retailers, consumer electronics companies, technology providers, and experts to analyze demand trends, technological progress, and competitive activities. Secondary research will involve analyzing reports published by companies and governments, industry journals, technology reports, industry publications, import-export data, and industry organizations in connection, display technologies, and consumer electronics industries. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, price dynamics, and investments.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea blood typing market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies
- Bio-Rad Laboratories
- Grifols
- Ortho Clinical Diagnostics
- Immucor
- Quotient Sciences
- DiaSorin F. Hoffmann-La Roche
- Abbott Laboratories
- Werfen and Thermo Fisher Scientific.
Recent Developments
- In April 2025, South Korea’s blood transfusion diagnostics market continued to advance with increasing adoption of PCR-based testing and high-throughput immunoassay platforms in public and private healthcare facilities. These technologies support improved blood screening, typing accuracy, and transfusion safety.
- In August 2025, advancements in blood typing and grouping technologies continued to support the South Korean transfusion diagnostics market, with growing demand for accurate blood-group identification and compatibility testing driven by transfusion services, chronic diseases, and surgical procedures.
Market Segmentation
South Korea blood typing market, By Product Type
- Consumables & Reagents
- Services & Software
South Korea blood typing market, By Technique
- Serology / Assay-Based Techniques
- Molecular (PCR-based and Microarray
South Korea blood typing market, By Test Type
- ABO Blood & Phenotype Tests
- Antibody Screening and Identification
- Cross-matching and Coombs Tests
South Korea blood typing market, By End-User
- Hospitals and Blood Banks
- Independent Clinical Diagnostic Laboratories
- Academic and Research Institutes
Expert Views
Experts consider the South Korea market stable and essential because blood typing is required before medical procedures. Growth will be supported by hospital automation, patient safety, population aging and the increasing use of diagnostic methods.
The main challenges are equipment costs, strict quality requirements, reagent storage conditions and the need for trained laboratory professionals. Smaller hospitals may prefer cost systems while large medical centers may invest in automation and molecular testing.
Author: Govind and Krishna By Decisions Advisors and Consulting